Generated Narrative: RegulatedAuthorization FOPH-21529 CH - EPL Reimbursement SL FOPHDossierNumber: FOPH Dossier Number/21529 status: Reimbursed statusDate: 2023-12-01 expiryDate: 2026-03-31 listingStatus: Listed listingPeriod: 2023-12-01 --> 2025-12-31 firstListingDate: 2023-12-01 costShare: 10 gamme: Oral CH - EPL Product Price value: CHF958.62 (CHF) type: Ex-factory price changeType: Price mutation after triennal review of pharmaceuticals changeDate: 2023-12-01 CH - EPL Product Price value: CHF1,113.95 (CHF) type: Retail price changeType: VAT-change changeDate: 2024-01-01 subject: PackagedProductDefinition: identifier = http://SMC.ch/ig/idmp/NamingSystem/IDSystem-ch-PCID#CH-7601001010604-6879301-001; containedItemQuantity = 30 Tablet; description = PAXLOVID Filmtabl 4x150mg/2x100mg type: Reimbursement SL Indications - Extension Reference * ClinicalUseDefinition: type = indication holder: Organization Pfizer AG Generated Narrative: Organization #holder-Pfizer-AG Profile: CH EPL Organization identifier: LOC Identifier/100015286, GLN Identifier/7601001010604 name: Pfizer AG
Price mutation after triennal review of pharmaceuticals